Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Testosterone and weight loss: the evidence.

Traish AM.

Curr Opin Endocrinol Diabetes Obes. 2014 Oct;21(5):313-22. doi: 10.1097/MED.0000000000000086. Review.

2.

Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.

Yassin DJ, Doros G, Hammerer PG, Yassin AA.

J Sex Med. 2014 Jun;11(6):1567-76. doi: 10.1111/jsm.12523. Epub 2014 Apr 8.

PMID:
24712761
3.

Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.

Saad F, Yassin A, Doros G, Haider A.

Int J Obes (Lond). 2016 Jan;40(1):162-70. doi: 10.1038/ijo.2015.139. Epub 2015 Jul 29.

4.

Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.

Saad F, Aversa A, Isidori AM, Gooren LJ.

Curr Diabetes Rev. 2012 Mar;8(2):131-43. Review.

5.

Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.

Salman M, Yassin DJ, Shoukfeh H, Nettleship JE, Yassin A.

Aging Male. 2017 Mar;20(1):45-48. doi: 10.1080/13685538.2016.1260107. Epub 2017 Jan 13.

PMID:
28084147
6.

The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease.

Traish AM, Zitzmann M.

Rev Endocr Metab Disord. 2015 Sep;16(3):249-68. doi: 10.1007/s11154-015-9323-2. Review.

PMID:
26590935
7.

Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study.

Haider A, Saad F, Doros G, Gooren L.

Obes Res Clin Pract. 2014 Jul-Aug;8(4):e339-49. doi: 10.1016/j.orcp.2013.10.005. Epub 2013 Nov 5.

PMID:
25091355
8.

Metabolic syndrome and hypogonadism--two peas in a pod.

Ebrahimi F, Christ-Crain M.

Swiss Med Wkly. 2016 Mar 21;146:w14283. doi: 10.4414/smw.2016.14283. eCollection 2016. Review.

9.

Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.

Haider A, Yassin A, Haider KS, Doros G, Saad F, Rosano GM.

Vasc Health Risk Manag. 2016 Jun 14;12:251-61. doi: 10.2147/VHRM.S108947. eCollection 2016.

10.

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.

Traish AM, Haider A, Doros G, Saad F.

Int J Clin Pract. 2014 Mar;68(3):314-29. doi: 10.1111/ijcp.12319. Epub 2013 Oct 15.

11.

Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).

Saad F.

Adv Exp Med Biol. 2017;1043:527-558. doi: 10.1007/978-3-319-70178-3_23. Review.

PMID:
29224109
12.

Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.

Giagulli VA, Carbone MD, Ramunni MI, Licchelli B, De Pergola G, Sabbà C, Guastamacchia E, Triggiani V.

Andrology. 2015 Nov;3(6):1094-103. doi: 10.1111/andr.12099. Epub 2015 Oct 7.

13.

Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.

Permpongkosol S, Tantirangsee N, Ratana-olarn K.

J Sex Med. 2010 Nov;7(11):3765-74. doi: 10.1111/j.1743-6109.2010.01994.x. Epub 2010 Aug 30.

PMID:
20807330
14.

[Testosterone and mortality].

Stárka L.

Vnitr Lek. Fall 2016;62(9 Suppl 3):127-130. Czech.

PMID:
27734705
15.

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.

Traish AM, Guay A, Feeley R, Saad F.

J Androl. 2009 Jan-Feb;30(1):10-22. doi: 10.2164/jandrol.108.005215. Epub 2008 Jul 17. Review.

16.

Testosterone deficiency and the metabolic syndrome.

Lunenfeld B.

Aging Male. 2007 Jun;10(2):53-6.

PMID:
17558968
17.

Testosterone for 'late-onset hypogonadism' in men?

[No authors listed]

Drug Ther Bull. 2010 Jun;48(6):69-72. doi: 10.1136/dtb.2010.01.0004.

PMID:
20530029
18.

A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.

Grossmann M, Matsumoto AM.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):1067-1075. doi: 10.1210/jc.2016-3580. Review.

19.

Testosterone and obesity.

Kelly DM, Jones TH.

Obes Rev. 2015 Jul;16(7):581-606. doi: 10.1111/obr.12282. Epub 2015 May 15. Review.

PMID:
25982085
20.

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.

Ann Intern Med. 1998 Jul 1;129(1):18-26.

PMID:
9652995

Supplemental Content

Support Center